|Articles|June 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-06-01-2001
  • Volume 0
  • Issue 0

Stocks: Catching the Market Blues

Author(s)Kevin Gopal

Buckinghamshire, UK-The pharma industry may be countercyclical, but it’s not immune to market trends. Nycomed Amersham recently postponed a partial US stock flotation of its life sciences company, ABBiotech, because of market weakness.

Articles in this issue

almost 25 years ago

Industry Under Investigation

almost 25 years ago

Emotion - The New Brand Integrator

almost 25 years ago

For Love of the Game

almost 25 years ago

Field of Dreams

almost 25 years ago

Workshop: Access Options

almost 25 years ago

Emotion - The New Brand Integrator

almost 25 years ago

Rx-to-OTC: Unwanted Attention

almost 25 years ago

Emotion - Biotech Renaissance Man

almost 25 years ago

Relocation: Coming to America

almost 25 years ago

Gathering Light

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content